Los Angeles Capital Management LLC Has $122.10 Million Stock Position in Lam Research Corporation $LRCX

Los Angeles Capital Management LLC grew its holdings in Lam Research Corporation (NASDAQ:LRCX) by 68.8% in the 2nd quarter, Holdings Channel reports. The fund owned 1,254,343 shares of the semiconductor company’s stock after purchasing an additional 511,377 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Lam Research were worth $122,098,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. BankPlus Wealth Management LLC lifted its stake in shares of Lam Research by 2.0% in the second quarter. BankPlus Wealth Management LLC now owns 5,248 shares of the semiconductor company’s stock valued at $511,000 after buying an additional 105 shares during the period. ORG Partners LLC boosted its stake in Lam Research by 7.3% during the second quarter. ORG Partners LLC now owns 1,676 shares of the semiconductor company’s stock worth $162,000 after buying an additional 114 shares in the last quarter. Quotient Wealth Partners LLC increased its holdings in Lam Research by 2.1% in the 2nd quarter. Quotient Wealth Partners LLC now owns 5,437 shares of the semiconductor company’s stock valued at $529,000 after buying an additional 114 shares during the period. Fairvoy Private Wealth LLC lifted its holdings in shares of Lam Research by 3.0% during the 2nd quarter. Fairvoy Private Wealth LLC now owns 4,185 shares of the semiconductor company’s stock worth $407,000 after acquiring an additional 120 shares during the period. Finally, Rosenberg Matthew Hamilton boosted its position in shares of Lam Research by 16.0% during the 2nd quarter. Rosenberg Matthew Hamilton now owns 869 shares of the semiconductor company’s stock valued at $85,000 after acquiring an additional 120 shares in the last quarter. 84.61% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total value of $207,667.02. Following the completion of the sale, the director owned 1,652 shares of the company’s stock, valued at approximately $264,303.48. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ava Harter sold 9,010 shares of the company’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the completion of the sale, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This represents a 13.69% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 62,498 shares of company stock valued at $8,875,663 over the last three months. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Down 1.8%

NASDAQ:LRCX opened at $159.35 on Friday. The company has a market cap of $200.15 billion, a price-to-earnings ratio of 35.10, a P/E/G ratio of 1.68 and a beta of 1.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The stock’s fifty day moving average price is $134.94 and its two-hundred day moving average price is $106.31. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $166.92.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same quarter last year, the business earned $0.86 earnings per share. The firm’s quarterly revenue was up 27.7% compared to the same quarter last year. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, analysts anticipate that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be given a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is currently 22.91%.

Wall Street Analysts Forecast Growth

LRCX has been the topic of a number of recent research reports. Wall Street Zen downgraded Lam Research from a “buy” rating to a “hold” rating in a report on Saturday. KeyCorp raised their target price on Lam Research from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Oppenheimer set a $200.00 price target on Lam Research and gave the company an “outperform” rating in a research report on Thursday, October 23rd. Dbs Bank lifted their price objective on Lam Research from $119.40 to $184.20 in a report on Monday, October 27th. Finally, Morgan Stanley boosted their target price on shares of Lam Research from $125.00 to $137.00 and gave the company an “equal weight” rating in a research note on Thursday, October 23rd. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $148.54.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.